Masimo Corp (NASDAQ:MASI) Institutional Investor Sentiment Is 1.09

Masimo Corporation (NASDAQ:MASI) Logo

Sentiment for Masimo Corp (NASDAQ:MASI)

Masimo Corp (NASDAQ:MASI) institutional sentiment decreased to 1.09 in 2018 Q2. Its down -0.02, from 1.11 in 2018Q1. The ratio dived, as 138 active investment managers increased and started new positions, while 127 sold and trimmed positions in Masimo Corp. The active investment managers in our partner’s database now own: 41.52 million shares, up from 41.18 million shares in 2018Q1. Also, the number of active investment managers holding Masimo Corp in their top 10 positions increased from 0 to 1 for an increase of 1. Sold All: 25 Reduced: 102 Increased: 88 New Position: 50.

Masimo Corporation, a medical technology company, develops, makes, and markets noninvasive monitoring technologies worldwide. The company has market cap of $5.65 billion. The firm offers Masimo Signal Extraction Technology pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It has a 41.2 P/E ratio. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index.

The stock decreased 1.56% or $1.69 during the last trading session, reaching $106.58. About 57,146 shares traded. Masimo Corporation (NASDAQ:MASI) has risen 36.40% since December 6, 2017 and is uptrending. It has outperformed by 20.78% the S&P500.

Analysts await Masimo Corporation (NASDAQ:MASI) to report earnings on February, 26. They expect $0.72 EPS, 0.00 % or $0.00 from last year’s $0.72 per share. MASI’s profit will be $38.16 million for 37.01 P/E if the $0.72 EPS becomes a reality. After $0.71 actual EPS reported by Masimo Corporation for the previous quarter, Wall Street now forecasts 1.41 % EPS growth.

Scholtz & Company Llc holds 2.96% of its portfolio in Masimo Corporation for 43,325 shares. Healthcor Management L.P. owns 747,040 shares or 2.32% of their US portfolio. Moreover, New Amsterdam Partners Llc Ny has 1.88% invested in the company for 81,277 shares. The Massachusetts-based Redwood Investments Llc has invested 1.79% in the stock. D L Carlson Investment Group Inc, a New Hampshire-based fund reported 51,091 shares.

Since January 1, 0001, it had 0 insider purchases, and 13 selling transactions for $74.75 million activity.

Masimo Corporation (NASDAQ:MASI) Ratings Coverage

Ratings analysis reveals 100% of Masimo’s analysts are positive. Out of 3 Wall Street analysts rating Masimo, 3 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $112 while the high is $145. The stock’s average target of $140.33 is 31.67% above today’s ($106.58) share price. MASI was included in 4 notes of analysts from August 2, 2018. The company was maintained on Tuesday, October 2 by Stifel Nicolaus. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, August 2 report.

More notable recent Masimo Corporation (NASDAQ:MASI) news were published by: Nasdaq.com which released: “Masimo (MASI) Scales a 52-Week High: What’s Driving It? – Nasdaq” on August 22, 2018, also Streetinsider.com with their article: “UBS Starts Masimo Corp. (MASI) at Buy – StreetInsider.com” published on November 27, 2018, Nasdaq.com published: “Masimo Corporation’s Momentum Continues With Impressive Earnings Growth – Nasdaq” on November 01, 2018. More interesting news about Masimo Corporation (NASDAQ:MASI) were released by: Nasdaq.com and their article: “Masimo Enters Oversold Territory (MASI) – Nasdaq” published on November 20, 2018 as well as Nasdaq.com‘s news article titled: “Report: Exploring Fundamental Drivers Behind Resonant, Constellation Brands, Masimo, Tetraphase Pharmaceuticals, LivaNova, and Penumbra — New Horizons, Emerging Trends, and Upcoming Developments – Nasdaq” with publication date: November 29, 2018.

Masimo Corporation (NASDAQ:MASI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.